Updates on Inter-agency work on Medical Devices IPC Meeting, WHO Geneva 6th June 2014 Medical devices Interagency list for reproductive , maternal, new born and child care Technical specifications – Nomenclature UNCLSC – 3 types of commodities involving 13 medical devices Pricing survey Future / on going Publications Compendium of innovative health technologies Pneumonia diagnostics. 2| IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 2008 Background 2011 2010 3| IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 4| IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Interagency list of medical devices for reproductive, maternal, newborn and child health Objective. Provide a publication containing a list with the essential interventions and medical devices related to them. UNFPA, UNICEF and WHO in collaboration with specific WHO areas: • • • • • • • • • • • 5| Injection Safety Blood transfusion Safe Surgery Diagnostic and Laboratory Reproductive Health Maternal Health Neonatal Health Waste management STI’s Infertility Cancer IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Meetings held – – – – – June 2012- Copenhagen August 2012-Geneva November 2012- Geneva February 2013- Copenhagen January 2014- Copenhagen FIRST MEETING Copenhagen, Denmark. June 27th-29th 2012 United Nations Population Fund (UNFPA) – – – – – Dr. Yves Bergevin, Senior Maternal Health Advisor, Coordinator, Maternal Health Thematic Fund, TD Dr. Kabir Ahmed, Technical Adviser, Commodity Security Branch Ms Wilma Doedens, Technical Adviser, Humanitarian Response Unit Ms Agnes Chidanyika, Technical Specialist Ms Isabel Lucas Manzano, Technical Consultant United Nations Children’s Fund (UNICEF) – – – – – – World Health Organization (WHO) – – – – 6| Ms Adriana Velazquez Berumen, Coordinator of Medical Devices Unit, Essential Medicines and Health Products Department Ms Åsa Cuzin-Kihl, Department of Reproductive Health and Research; Research Capacity, Policy and Programme Strengthening Dr Metin Gulmezoglu, Department of Reproductive Health and Research Ms Lisa Hedman, Essential Medicines and Health Products IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 – – – – – Dr Hanne Bak Pedersen, Deputy Director, UNICEF Supply Division Dr Kim Eva Dickson, Senior Adviser (Maternal and Newborn Health), Health Section UNICEF HQ Dr Helene Moller, Chief, Health Technology Centre, UNICEF Supply Division Mr Francisco Blanco, Chief, Medicines & Nutrition, UNICEF Supply Division Mr Thomas Sorensen, Chief, Knowledge Management, UNICEF Supply Division Ms Etleva Kadilli, Contracts Manager, Medical Unit, Health Technology Centre, UNICEF Supply Division Dr David Muhia, Contracts Manager, Medicines & Nutrition, UNICEF Supply Division Ms Monique Supiot, Technical Officer, Health Technology Centre, UNICEF Supply Division Mr Ludo Scheerlinck, Technical Officer, Medical Unit, Health Technology Centre, UNICEF Supply Division Mr Henrik K. Nielsen, Technical Specialist, Medicines & Nutrition, UNICEF Supply Division Ms Clara Aranda-Jan, Consultant, Medical Unit, Health Technology Centre, UNICEF Supply Division SECOND MEETING Geneva, Switzerland. August 6th-7th 2012. United Nations Population Fund (UNFPA) – – – – Ms Isabel Lucas Manzano, Technical Consultant Ms Wilma Doedens, Technical Adviser, Humanitarian Response Unit – – – World Health Organization (WHO) – – – – – 7| Ms Adriana Velazquez Berumen, Coordinator of Medical Devices Unit, Essential Medicines and Health Products Department Ms Lisa Hedman, Essential Medicines and Health Products Ms Clara Aranda-Jan, Consultant, Medical Devices Unit, Essential Medicines and Health Products Department Ms Alicia de Hoyos Reyes, Intern, Medical Devices Unit,, Essential Medicines and Health Products Department Dr Viviana MANGIATERRA, Scientist IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Dr Meena NATHAN CHERIAN, Medical Officer, Clinical Procedures Unit Ms Anita SANDS, Technical Officer, Diagnostic and Laboratory Technologies Dr Selma KHAMASSI, Medical Officer, Clinical Procedures Unit Dr Neelam DHINGRA-KUMAR, Coordinator Health Policy, Development and Services Ms María Mercedes PEREZ GONZALEZ, Technical Officer, Diagnostic and Laboratory Technologies United Nations Children’s Fund (UNICEF) – Ms Monique Supiot, Technical Officer, Health Technology Centre, UNICEF Supply Division THIRD MEETING Geneva, Switzerland. November 12-14th 2012. United Nations Population Fund (UNFPA) – – United Nations Children’s Fund (UNICEF) – – Ms Clara Aranda, Technical Consultant Ms Monique Supiot, Technical Officer, Health Technology Centre, UNICEF Supply Division – – – – – World Health Organization (WHO) – 8| Ms Isabel Lucas Manzano, Technical Consultant Ms Wilma Doedens, Technical Adviser, Humanitarian Response Unit Ms Adriana Velazquez Berumen, Coordinator, Diagnostic Imaging and Medical Devices, Essential Medicines and Health Products IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 – Ms Alejandra Velez Ruiz Gaitan, Technical Officer, Diagnostic Imaging and Medical Devices, Essential Medicines and Health Products Ms Alicia De Hoyos Reyes, Intern, Diagnostic Imaging and Medical Devices, Essential Medicines and Health Products Ms Anita Sands, Technical Officer, Diagnostic and Laboratory Technologies, Essential Medicines and Health Products Dr Maurice Bucagu, Medical Officer, Policy, Planning and Programmes Dr James Farukai Tsimba Chitsva, Technical Officer, Blood Transfusion Safety, Health Policy, Development and Services Dr Mario Festin, Lead Specialist, Promoting Family Planning – – – – – Dr Selma Khamassi, Medical Officer, Clinical Procedures Unit, Health Policy, Development and Services Dr Viviana Mangiaterra, Scientist, Research Capacity, Policy and Programme Strengthening Dr Meena Nathan Cherian, Medical Officer, Clinical Procedures Unit, Health Policy, Development and Services Dr Severin Ritter Von Xylander, Medical Officer, Policy, Planning and Programmes Ms Susan Wilburn, Technical Officer, Interventions for Healthy Environments Methodology From the Copenhagen meeting and the workshops held at WHO the following was agreed: – Life cycle and continuum of care of mother and newborn to be considered: • Family Planning • Pregnancy • Childbirth • Post-natal and mother • Newborn – Level of delivery of intervention: • Community level (Includes Health Post) • First level (Includes Health Center) • Referral level (Includes District Hospital and Referral Hospital) 9| IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Interventions were reviewed according to evidence-based guidelines from WHO and with specialists. 10 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 11 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Health Care Facilities considered Health Post District Hospital 12 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Health Center Referral Specialized Hospital 13 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 FAMILY PLANNING TEMPLATE Medical Devices 14 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Interventions Interventions for Newborn 15 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Medical Devices 16 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Special notes Part A. Special notes related to program • • • • • • Safe blood and Clinical transfusion Diagnostic tests & Laboratory Injection safety Surgery and Anesthesia Decontamination and sterilization at healthcare facilities Health care waste management Part B. Special notes related to medical devices • • • • • • • 17 | Regulations for medical devices Health Technology Management Label and instructions for use for medical devices Units and biomaterials used for medical devices Surgical instruments stainless steel Surgical sutures Textiles used for linen and clothing in healthcare facility IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Groups of medical devices Groups of medical devices 1. Grouping of common medical equipment by clinical area in health-care facility 2. Grouping of common surgical instruments by surgical procedure 3. Grouping of medical device consumables by size and capacity 18 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Interagency list of medical devices for reproductive, maternal, newborn and child health , June 2014 19 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 UN Commission on life saving commodities Defining a list of overlooked life-saving commodities for women and children Identifying key barriers preventing access to and use of these commodities Recommending innovative action to rapidly increase both access and use 20 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 List of medical devices for UN Commission on Life Saving Commodities Reproductive health commodities • Female condom Injectable antibiotics for newborn sepsis Resuscitation devices for newborn asphyxia • Self-inflating neonatal resuscitation bag with masks for pre-term(size 0) and term(size 1) babies • Electric or foot operated suction machine/pump, negative pressure less than 100mm Hg, with 1 bottle • Syringe 2 mL with needle 23 G 25 mm • (with re-use prevention feature) • Suction catheter , length 50 cm, single use, conical tip, Fr # 8 • Syringe 2 mL with needle 23 G 25 mm (without re-use prevention feature) • Single use suction bulb • Sharps container, for used syringes/needles • Infant scale less than 20 kg • Clinical thermometer, non-mercury 21 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 • Multi-use suction bulb that can be opened, cleaned and sterilized • Training mannequin/simulator for neonatal resuscitation • Infant stethoscope Dosage for Neonates 22 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Tools for country assessment v1 23 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Technical specifications by UN agencies, can harmonization be possible? UNICEF Supply catalogue UNOPS UN Webbuy https://supply.unicef.org/ WB has requested UNFPA AccessRH https://myaccessrh.org/ 24 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 https://unwebbuy.org/ Other sources of technical specifications NGO’s, countries… 25 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Technical Specifications 1. Medical Device Specification 2. Name and Coding 3. General 4. Technical 1. 2. 3. 4. 5. Bidding / Procurement Terms / Donation Requirements 1. 2. 3. 4. 5. 26 | Technical Characteristics Physical Characteristics Energy Source Accessories, Spare Parts, Consumables Environmental and Departmental Considerations Standards and Safety Training and Installation Warranty and Maintenance Documentation IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Example of Female Condom(1) NAME, CATEGORY AND CODING 6 7 WHO Category Generic name 8 Specific type or variations 9 GMDN name Female condom Female condom, Hevea-latex and Female condom, non latex 10 GMDN code(s) 47721 47722. 11 GMDN category 10 Single-use devices 11 Assistive products for persons with disability 12 UMDNS name 13 UMDNS code 14 UNSPS code Condoms, Female 18079 53131622 15 Alternative name(s) Contraceptive Femidom Condoms Condoms, female Pouch, intravaginal Prophylactic 16 Alternative code(s) MS 35772, 206402008 MS 43386 MS 10985, 10985 MS 18079, 18079 MS 34045, MBU MS 44542, 289906000 27 | Nomenclature GMDN, UMDNS, UNSPS Which nomenclature to use? 17 Keywords Contraceptive device, Pregnancy prevention, prevention of sexually transmitted infections(STI) including HIV, AIDS, syphilis, gonorrhoea, chlamydia, trichomoniasis 18 GMDN definition 47721; A Hevea-latex sheath with rings on either end that is inserted into the vagina before coitus to prevent sperm from gaining access to the female reproductive tract and/or to prevent the transmission of sexually transmitted infections (STI) between sexual partners. This is a single-use device. 47722; A sheath made of synthetic polymers (e.g., polyurethane or nitrile) with rings on either end that is inserted into the vagina before coitus to prevent sperm from gaining access to the female reproductive tract and/or to prevent the transmission of sexually transmitted infections (STI) between sexual partners. It typically includes a lubricant to minimize friction during coitus. This is a single-use device IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Example of Female Condom(2) PURPOSE OF USE 19 Clinical purpose Barrier to prevent unwanted pregnancy and transmission of STIs and HIV 20 Level of institution Individual level, as given in the user leaflet/labelling 21 Clinical department/ward Not applicable 22 Overview of functional requirements 23 Risk Classification Lines vaginal canal and is designated to be retained in vagina during sexual intercourse to prevent unwanted pregnancy and transmission of STIs. The external component of the devices can provide coverage to the external female genitalia. Class C (GHTF Rule 17) Class Ⅱb (EU) Class Ⅱ (Japan) Class Ⅲ (USA) Risk classification IMDRF/GHTF (International Medical Device Regulators Forum/ Global Harmonization Task Force) http://www.imdrf.org/ TECHNICAL CHARACTERISTICS 24 Detailed requirements Female condoms come in different designs and materials therefore Dependent on manufacturer's specifications and WHO/UNFPA specifications and ISO standard. 25 Displayed parameters Female condoms come in different designs and materials therefore Dependent on manufacturer's specifications and WHO/UNFPA specifications and ISO standard. IPC Meeting, WHO, Switzerland settings NotGeneva, applicable 2628User | adjustable 6th June 2014 Example of Female Condom(3) PACKAGING Sterility status on delivery 30 (if relevant) 31 Shelf life (if relevant) N/A The claimed shelf life shall be not less than three years and not more than seven years subject to confirmation by appropriate stability data The inner boxes shall be packed into plastic or other waterproof lining bags, which will be placed in three-wall cartons made from weather-resistant corrugated fibreboard with a bursting test strength of not less than 1900 kPa.The inner boxes will be marked in a legible manner to facilitate identification in case of subsequent query. The carton flaps shall be secured with water-resistant adhesive applied to not less than 75% of the area of contact between the flaps, or with water-resistant tape, 75 mm wide, applied to the full length of the centre seams and extending over the ends by not less than 75 mm. The cartons may be secured by plastic strapping at not less than two positions. Alternatively, wire-bound, cleated plywood or nailed wood boxes are acceptable when lined with a waterproof barrier material. The barrier material must be sealed at the edges with waterproof tape or adhesive, and there must be no sharp protrusions inside the boxes. Packaging Shelf life, transportation, Labelling Transportation and 32 storage (if relevant) 33 Labelling (if relevant) The exterior shipping carton, like the inner box, shall be marked with information about the contents in a clearly legible manner. Information should be printed on two adjacent sides. The following information should be included in the inner box marking and exterior shipping carton. The information shall include: • a description of the contents; • Lot identification number; • month and year of manufacture (including the words Date of Manufacture, Month, Year) in language(s) to be specified by the purchaser. The year shall be written as a four-digit number and the month as a twodigit number; • month and year of expiry (including the words Expiry Date, Month, Year) in language(s) to be specified by the purchaser. The year shall be written as a four-digit number and the month as a two-digit number; • name and address of the manufacturer and/or supplier; • number of female condoms contained in the carton; • the consignee details; • instructions for storage and handling. N/A ENVIRONMENTAL REQUIREMENTS 29 | IPC Meeting, WHO, Geneva, Switzerland 34 6th June 2014 Context-dependent requirements Female condoms should be stored away from extreme heat (not more than 35 degrees C), be protected from moisture and direct sunlight in a well ventilated environment. Example of Female Condom(4) STANDARDS AND SAFETY 46 Risk Classification Regulatory Approval / 47 Certification Standards: e.g. Quality management systems(ISO13485), Standards for electric 48 International standards devices(IEC),Female condoms-- requirements and test methods(ISO25841) Which standards to include? Reginal / Local 49 Standards 50 Regulations 30 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Class C (GHTF Rule 17), Class Ⅱb (EU, Australia), Class Ⅱ (Japan, Canada), Class Ⅲ (USA) FDA approval(USA); CE mark(EU) ISO 13485:2003 Medical devices -- Quality management systems -- Requirements for regulatory purposes (European Union, Canada and Australia) ISO 14971:2007 Medical devices -- Application of risk management to medical devices ISO/IEC 17025:2005 General requirements for the competence of testing and calibration laboratories ISO 2859-1:1999 Sampling procedures for inspection by attributes -- Part 1: Sampling schemes indexed by acceptance quality limit (AQL) for lot-by-lot inspection ISO 10993–1:2009 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process ISO 10993–5: 2009 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity ISO 10993–10:2010 Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization ISO 11346:2004 Rubber, vulcanized or thermoplastic -- Estimation of life-time and maximum temperature of use ISO 4074:2002 Natural latex rubber condoms -- Requirements and test methods Cor 1:2003 Cor 2:2008 ISO 25841:2011 Female condoms -- Requirements and test methods ASTM D7661-10 Standard Test Method for Determining Compatibility of Personal Lubricants with Natural Rubber Latex Condoms (USA) US regulations 21 CFR part 820; 21CFR Section 884.5330 (USA); EU regulations Council Directive 93/42/EEC Directive 93/68/EEC (CE Marking) WHO technical specifications of 70 medical devices including UNCLSC devices 1 Abortion suction system 41 Overhead infant phototherapy unit 21 Infant Resuscitation Table 2 Anaesthesia Ventilator 42 Peak Flow Meter 22 Infrared thermometer, ear 3 Bilirubinometer 43 Physiologic Monitoring System 23 Infrared thermometer, skin 4 Capillary patient thermometer 44 Portable Ventilator Electric 24 Intensive-care ventilator 5 Cardiovascular ultrasound 45 PulseOximeter Line Powered 25 Laboratory urine analyser IVD 6 CPAP unit 46 PulsoOximeter Battery Powered 26 Laboratory water bath 7 Cryosurgical Unit 47 Scale Patient Infant 27 Laryngoscope 8 Darkroom Automatic X-ray Film processor 48 Single Channel Electrocariograph 28 Manual Emergency Suction System 9 Daylight Automatic Xray Film Processor 49 Sphygmomanometer 29 Microscope Light 10 Diagnostic spirometer Stationary Basic Diagnostic Xray 30 Mobile basic diagnostic x-ray system, analogue 11 Electrocardiographic monitor 50 System Analogue 31 Mobile basic diagnostic x-ray system, digital Stationary Basic Diagnostic Xray 12 Examination Treatment Light 32 Mobile flouroscopic x-ray system, analogue 51 System Digital 13 Floor Scale electronic 33 Mobile flouroscopic x-ray system, digital 52 Stethoscope mechanical 14 Floor Scale mechanical 34 Neonatal physiologic monitoring systems53 Suction system 15 Foetal cardiac monitor 35 Non-rechargeable professional semi-automated 54 Syringexternal Pump defibrillator 16 Foetal vacuum extraction 36 Obstetrical table, line-powered 55 Thermometer laboratory 17 General purpose Electrosurgical Diathermy 37 Obstetrical table, manual 56 Transport infant incubator 18 General purpose Tabletop Centrifuge 38 Operating light (fixed) Universal operating table 19 General purpose Ultrasound 39 Ophthalmoscope, direct 57 electrohydraulic 20 Incubator Infant Stationary 40 Otoscope, direct Universal operating table 58 electromechanic 59 Universal operating table hydraulic 60 Unwrapped steam sterilizer 61 Viewbox X-ray 31 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 62 Female condom 63 Syringe 2 mL with needle 23 G 25mm (with re-use prevention feature) 64 Syringe 2 mL with needle 23 G 25mm (without re-use prevention feature) 65 Sharps container, for used syringes/needles 66 Self-inflating neonatal resuscitation bag with masks for pre-term and term babies 67 Suction catheter , length 50 cm, single use, conical tip, Fr# 8 68 Single use suction bulb 69 Multi-use suction bulb that can be opened, cleaned and sterilized 70 Training manikin/simulator for neonatal resuscitation Consideration 1) WHO technical specifications should be tailored appropriately by users according to the specific situation, e.g. local standards and legislation; local regulations and conditions; languages; electrical range, capacities, utility environment and other local specific conditions. 2) Technical characteristics of WHO technical specifications are indicate basically appropriate standard equipment for low- and middle- income countries. 3) The number of accessories, consumables, spare parts and other components indicates usual and/or ideal number, not mandatory. 4) For tender purposes, should consider not only medical equipment itself, also related services to be able to use the equipment, e.g. installation, supplier testing, training, warranty. 32 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Three Dimensions to Consider When Moving Towards Universal Coverage Health systems financing: the path to universal coverage. Executive Summary, The World Health Report, WHO/IER//WHR/10.1, 2010 33 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 WHO Global medical devices pricing survey 2014 • • • Collect data in different stakeholders and settings Statistical analysis Report findings of the pricing survey Global medical devices pricing survey 34 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Innovation Universities Medical devices industry HOSPITAL SERVICES BIOMEDICAL ENGINEERING: SELECTION, USE , MAINTENANCE OF EQUIPMENT Safety and quality . Regulatory institutions HTA, SELECTION OF PRIORITY MEDICAL DEVICES MEDICAL DEVICES FOR REIMBURSEMENT, FOR COVERAGE , 35 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Medical devices technical series 36 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Books on medical devices for 20142015: – Regulations ( pre-market, postmarket) – Safe use of medical devices – Human resources – Decommissioning 37 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Image of the linkage with data sources 38 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 WHO medical devices information system (MEDEVIS) the development in 2014 Clinical information Global Atlas, MDs by health care facilities… • • Disease related to procedure Clinical indication Procedural use of medical devices Areas of use within a given health care system • • • linkage Region/healthcare system Type of facility Group of healthcare section Medical device information Pricing survey, Compendium, Nomenclature…. 39 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Interagency list, Other sources… • • • • • Device name Description/Definition Technical information Picture Economic information • • • • Procedural information Regulatory information Procurement information Assessment information Technical specifications, Other sources.. Structure of MEDEVIS web tool as per WHA60.29 - Review data sources and linking points Design appropriate data-structure for MEDEVIS to be able to link various data sources 40 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 2010 call for innovative technologies that address global health concerns: outcomes 41 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 2011-2013 Compendium 42 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 43 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Pneumonia: UNICEF and WHO Pneumonia is the leading cause of death in children worldwide. Pneumonia kills an estimated 1.4 million children under the age of five years every year – more than AIDS, malaria and tuberculosis combined. Pneumonia can be caused by viruses, bacteria or fungi. Pneumonia can be prevented by immunization, adequate nutrition and by addressing environmental factors. No diagnostic method is available for low resource settings. 44 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 + Novel Diagnostic Tools for Childhood Pneumonia Access to antibiotics Vitamin A Pneumococcal vaccination Other vaccines Prevention Malaria Pneumonia Oxygen Saturation Viral Pneumonia Fever Tachycardia Bacterial Pneumonia Treatment BIOMARKERS: PCT, CRP, Lpc-2, Heptoglobin… Crackles Antibiotic Resistance Other infections Wheezing Respiratory Rate Chest X-ray Treatment Diagnosis + Country survey , 2013 data: Country survey on Medical devices. Update 2013. 47 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Approved medical devices for national procurement or reimbursement 48 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Lists of devices per facility or clinical procedure Examples: Per hospital Per health center Per area of care: – ICU – Surgery Per disease – H1N1 – HIV – Vaccines 49 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 WHO Medical Devices Publications (2008-2014) Country Publications WHO Regions 50 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Next steps… – Circulate for revision: the interagency book on medical devices for essential interventions on reproductive, maternal, new born and child care. And publish. – UNCLSC define final tech specs, PQ available, regulatory pathway – Harmonize the format of the technical specifications? – Nomenclature work? – Participate in the pricing survey? – Participate in the evaluation of the innovative technologies? For the compendium on innovative technologies? – Participate in the next books: • Decommissioning of medical devices • Safe use of medical devices. 51 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014 Thank you ! www.who.int/medical devices velazquezberumena@who.int Medical_devices@who.int 52 | IPC Meeting, WHO, Geneva, Switzerland 6th June 2014